Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials
The DOI matches its Crossref record.
Abstract
Objective: Suicide is a global health concern, and innovative interventions that target suicidality are needed. While psychedelic therapy shows promise for a range of mental health concerns, including suicidality, not all psychedelic therapy trials have published their suicidality results and no meta-analysis has been published on the topic. Therefore, we completed the first meta-analysis of patient-level data on the effects of psychedelics on suicidality. Data Sources: We conducted a systematic search of MEDLINE, PsycINFO, and PubMed for all psychedelic therapy clinical trials (last search: November 5, 2020). Study Selection: We identified all psychedelic therapy trials that included a measure or measure-item that assesses suicidality. Data Extraction: Suicidality data were requested from study authors and extracted using a data extraction form developed for this study. Results: We identified 8, and successfully collected data from 7, relevant trials. Analysis of standardized mean differences (SMDs) indicated that, relative to baseline, psychedelic therapy was associated with large effect sizes for acute (80–240 min) and sustained (1 day, 1–8 weeks, and 3–4 months) decreases in suicidality (SMD range = −1.48 to −2.36; 95% CI range, −4.30 to 0.23). At 6 months, the effect size was medium (SMD = −0.65; 95% CI, −1.14 to −0.16). Reductions in suicidality were significant at all time points except for 7–8 weeks. Acute and post-acute elevations in suicidality were rare (6.5% and 3.0%, respectively). Conclusions: Limitations include heterogeneous samples and interventions, as well as limited sample size and number of studies. Results provide preliminary support for the safety of psychedelic therapy and its positive effect on suicidality. Controlled trials that specifically evaluate the effect of psychedelic therapy on suicidality may be warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Psychiatric risks for worsened mental health after psychedelic use
Marrocu, A., Kettner, H., Weiss, B., Zeifman, R. J., Erritzoe, D., & Carhart-Harris, R. L. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241232548 · Cited by 60
“…substance abuse (Bogenschutz et al., 2015; Bouso et al., 2008; Carhart-Harris et al., 2021b) including improvements in some key symptoms of BPD (e.g., suicidality, emotion dysregulation, self-image) (Argento et al., 2017; Domínguez-Clavé et al., 2019; Soler et al., 2018; Zeifman et al., 2022).”
BackgroundSelf-citationHull, T. D., Malgaroli, M., Gazzaley, A., Akiki, T. J., Madan, A., Vando, L., Arden, K., Swain, J., Klotz, M., & Paleos, C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.004 · Cited by 58
“The large reductions in suicide ideation for KAT replicate those in more controlled settings (Abbar et al., 2022; Zeifman et al., 2022) and reiterate the potential utility of dissociative and psychedelic compounds for rapidly reducing suicide ideation and behavior.”
Epigenetic Mechanisms of Rapid-Acting Antidepressants
Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03055-y · Cited by 27
“Despite the fact that the use of RAADs has been associated with decreased likelihood of suicide [75, 76], DNA hypermethylation is also observed in the blood of individuals who attempted suicide [77] and in the PFC of suicide completers [78].”
Background
Metadata
- Authors
- Zeifman, R. J., Yu, D., Singhal, N., Wang, G., Nayak, S. M., & Weissman, C. R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2022-01-18
- Volume
- 83
- Issue
- 2
- ISSN
- 0160-6689 (ISSN-L)
- 1555-2101
- OpenAlex
- W4206661393
- Cited by
- 35
- References
- 0
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials. https://app.cochat.ai/papers/10.4088/jcp.21r14057
- The paper
- Zeifman, R. J., Yu, D., Singhal, N., Wang, G., Nayak, S. M., & Weissman, C. R. (2022). Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.21r14057
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.